Insomnia in Brilinta - how severe and when it was recovered? (a real world drug study)

Summary:

We study how severe was Insomnia, when it was recovered, drug effectiveness, race, and more among people who take Brilinta (ticagrelor). This phase IV clinical study is created by eHealthMe based on reports submitted to eHealthMe, and is updated regularly.

What is Brilinta?

Brilinta has active ingredients of ticagrelor. It is often used in stent. eHealthMe is studying from 22,469 Brilinta users. Check the latest studies of Brilinta.

What is Insomnia?

Insomnia (sleeplessness) is found to be associated with 3,115 drugs and 5,173 conditions by eHealthMe. Check the latest studies of Insomnia.

eHealthMe: drug outcomes in the real world

eHealthMe runs one of the largest post-marketing drug safety studies in the world. We study millions of patients and 5,000 more each day. Our data-driven phase IV clinical trials have been referenced on 800+ peer-reviewed medical publications including The Lancet, Mayo Clinic Proceedings, and Nature. Tools to study our phase IV findings are available to the public, anonymous and free >>>.

On Jun, 08, 2026

9 people who have Insomnia while taking Brilinta were studied.

Severity of Insomnia *:

least: 0.0 %
moderate: 44.44 %
severe: 44.44 %
most severe: 11.11 %

When people recovered from Insomnia *:

while on drug: 0.0 %
after off the drug: 0.0 %
not yet: 100 %

Effectiveness of Brilinta *:

not at all: 16.67 %
somewhat: 0.0 %
moderate: 50.0 %
high: 16.67 %
very high: 16.67 %

Race of the people *:

African American, Non-Hispanic: 12.5 %
American Indian/Alaska Native: 0.0 %
Asian: 0.0 %
Hispanic: 0.0 %
Native Hawaiians/Pacific Islanders: 0.0 %
Two or more races: 0.0 %
White, Non-Hispanic: 87.5 %

Time on Brilinta *:

Gender of people when taking Brilinta *:

female: 22.22 %
male: 77.78 %

Age of people when taking Brilinta *:

Conditions people have *:

High Blood Pressure: 4 people, 44.44%
High Blood Cholesterol: 3 people, 33.33%
Heart Failure: 2 people, 22.22%
Blood Clots: 2 people, 22.22%
Weight Loss: 1 person, 11.11%
Type 1 Diabetes: 1 person, 11.11%
Stress And Anxiety: 1 person, 11.11%
Sleep Sex (a condition in which a person will engage in sexual activities while still asleep): 1 person, 11.11%
Seizures (abnormal excessive or synchronous neuronal activity in the brain): 1 person, 11.11%
Heart Disease: 1 person, 11.11%

Other drugs people take besides Brilinta *:

Other side effects people have besides Insomnia *:

Restless Leg Syndrome (a powerful urge to move your legs): 3 people, 33.33%
Fatigue (feeling of tiredness): 2 people, 22.22%
Orthostatic Collapse (sudden low blood pressure due to posture change): 1 person, 11.11%
Knee Pain: 1 person, 11.11%
Itching: 1 person, 11.11%
Heart Rate Increased: 1 person, 11.11%
Gastrointestinal Discomfort: 1 person, 11.11%
Eyelid Twitch (spontaneous and uncontrolled spasms of the muscles): 1 person, 11.11%
Eye Redness: 1 person, 11.11%
Dizziness: 1 person, 11.11%

* Approximation only. Some reports may have incomplete information.

Do you take Brilinta and have Insomnia?

Check whether Insomnia is associated with a drug or a condition

How to use the study?

DO NOT STOP MEDICATIONS without first consulting your doctor. If there are any serious or long term adverse effects discovered in the study, discuss the study with your doctor to ensure that proper medication management will be in place if applicable.

Related studies

Insomnia in Brilinta

How the study uses the data?

The study is based on ticagrelor (the active ingredients of Brilinta). Other drugs that have the same active ingredients (e.g. generic drugs) are considered. Dosage of drugs is not considered in the study.

Who is eHealthMe?

With medical big data and proven AI/ML algorithms, eHealthMe provides a platform for everyone to run phase IV clinical trials. We study millions of patients and 5,000 more each day. Results of our real-world drug study have been referenced on 800+ peer-reviewed medical publications, including The Lancet, Mayo Clinic Proceedings, and Nature. Our analysis results are available to researchers, health care professionals, patients (testimonials), and software developers (open API).

WARNING, DISCLAIMER, USE FOR PUBLICATION

WARNING: Please DO NOT STOP MEDICATIONS without first consulting a physician since doing so could be hazardous to your health.

DISCLAIMER: All material available on eHealthMe.com is for informational purposes only, and is not a substitute for medical advice, diagnosis, or treatment provided by a qualified healthcare provider. All information is observation-only. Our phase IV clinical studies alone cannot establish cause-effect relationship. Different individuals may respond to medication in different ways. Every effort has been made to ensure that all information is accurate, up-to-date, and complete, but no guarantee is made to that effect. The use of the eHealthMe site and its content is at your own risk.

If you use this eHealthMe study on publication, please acknowledge it with a citation: study title, URL, accessed date.